相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Human FOXP3 and tumour microenvironment
Jia Wang et al.
IMMUNOLOGY (2023)
Cisplatin nephrotoxicity: new insights and therapeutic implications
Chengyuan Tang et al.
NATURE REVIEWS NEPHROLOGY (2023)
Evaluation of Baculoviruses as Gene Therapy Vectors for Brain Cancer
Matias Garcia Fallit et al.
VIRUSES-BASEL (2023)
A recombinant adenovirus vector containing the synNotch receptor gene for the treatment of triple-negative breast cancer
A. Ruhan et al.
FRONTIERS IN ONCOLOGY (2023)
Breast Cancer Vaccines: Disappointing or Promising?
Si-Yuan Zhu et al.
FRONTIERS IN IMMUNOLOGY (2022)
Immunotherapy of Cancer by Targeting Regulatory T cells
Bo-Jin Chen et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2022)
Hitting Multiple Cellular Targets in Triple-Negative Breast Cancer Using Dual-Action Cisplatin(IV) Prodrugs for Safer Synergistic Chemotherapy
Tushar Date et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2022)
Phase 1b study of berzosertib and cisplatin in patients with advanced triple-negative breast cancer
Melinda L. Telli et al.
NPJ BREAST CANCER (2022)
Significance of Preexisting Vector Immunity and Activation of Innate Responses for Adenoviral Vector-Based Therapy
Wen-Chien Wang et al.
VIRUSES-BASEL (2022)
The expression landscape of FOXP3 and its prognostic value in breast cancer
Jingping Li et al.
ANNALS OF TRANSLATIONAL MEDICINE (2022)
Neglected, yet significant role of FOXP1 in T-cell quiescence, differentiation and exhaustion
Yaroslav Kaminskiy et al.
FRONTIERS IN IMMUNOLOGY (2022)
The expression landscape of FOXP3 and its prognostic value in breast cancer
Jingping Li et al.
ANNALS OF TRANSLATIONAL MEDICINE (2022)
Regulatory T cell targeting in cancer: Emerging strategies in immunotherapy
Sundee Dees et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2021)
Searching for Peptide Inhibitors of T Regulatory Cell Activity by Targeting Specific Domains of FOXP3 Transcription Factor
Teresa Lozano et al.
BIOMEDICINES (2021)
FOXP3 Inhibits the Metastasis of Breast Cancer by Downregulating the Expression of MTA1
Chenlin Liu et al.
FRONTIERS IN ONCOLOGY (2021)
Viral vector platforms within the gene therapy landscape
Jote T. Bulcha et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Molecular Mechanisms Controlling Foxp3 Expression in Health and Autoimmunity: From Epigenetic to Post-translational Regulation
Alessandra Colamatteo et al.
FRONTIERS IN IMMUNOLOGY (2020)
The FKH domain in FOXP3 mRNA frequently contains mutations in hepatocellular carcinoma that influence the subcellular localization and functions of FOXP3
Jianwei Ren et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Humanin Promotes Tumor Progression in Experimental Triple Negative Breast Cancer
Mariela A. Moreno Ayala et al.
SCIENTIFIC REPORTS (2020)
Rapamycin increases the incidence of neuropsychiatric illness in kidney transplant patients through the suppression of neural stem cells
Yangsik Kim et al.
TRANSLATIONAL PSYCHIATRY (2020)
Cell-Penetrating Peptides Escape the Endosome by Inducing Vesicle Budding and Collapse
Ashweta Sahni et al.
ACS CHEMICAL BIOLOGY (2020)
Rapamycin and abundant TCR stimulation are required for the generation of stable human induced regulatory T cells
Juewan Kim et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2020)
PD-L1 is a direct target of cancer-FOXP3 in pancreatic ductal adenocarcinoma (PDAC), and combined immunotherapy with antibodies against PD-L1 and CCL5 is effective in the treatment of PDAC
Xiuchao Wang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Regulatory T cells in cancer immunosuppression - implications for anticancer therapy
Yosuke Togashi et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Targeting Treg cells in cancer immunotherapy
Atsushi Tanaka et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2019)
TGF--Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis
Yang Hao et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
FOXP3 Inhibitory Peptide P60 Increases Efficacy of Cytokine-induced Killer Cells Against Renal and Pancreatic Cancer Cells
Maria Fitria Setiawan et al.
ANTICANCER RESEARCH (2019)
Direct impact of cisplatin on mitochondria induces ROS production that dictates cell fate of ovarian cancer cells
Markus Kleih et al.
CELL DEATH & DISEASE (2019)
Characterization of immune cell subtypes in three commonly used mouse strains reveals gender and strain-specific variations
Jonathan A. Hensel et al.
LABORATORY INVESTIGATION (2019)
Prolactin and its receptor as therapeutic targets in glioblastoma multiforme
Antonela Sofia Asad et al.
SCIENTIFIC REPORTS (2019)
Past, Present, and Future of Regulatory T Cell Therapy in Transplantation and Autoimmunity
Marco Romano et al.
FRONTIERS IN IMMUNOLOGY (2019)
From IPEX syndrome to FOXP3 mutation: a lesson on immune dysregulation
Rosa Bacchetta et al.
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2018)
FOXP3 inhibits angiogenesis by downregulating VEGF in breast cancer
Xiaoju Li et al.
CELL DEATH & DISEASE (2018)
Limited Foxp3+ Regulatory T Cells Response During Acute Trypanosoma cruzi Infection Is Required to Allow the Emergence of Robust Parasite-Specific CD8+ T Cell Immunity
Cintia L. Araujo Furlan et al.
FRONTIERS IN IMMUNOLOGY (2018)
FoxP3 Expression in Macrophages, Cancer, and B Cells-Is It Real?
Zahava Vadasz et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2017)
Immunotherapy for the treatment of breast cancer
Mariela A. Moreno Ayala et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2017)
Viral gene therapy for breast cancer: progress and challenges
Antonela S. Asad et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2017)
Dual activation of Toll-like receptors 7 and 9 impairs the efficacy of antitumor vaccines in murine models of metastatic breast cancer
Mariela A. Moreno Ayala et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2017)
Downregulation of FOXP3 inhibits cell proliferation and enhances chemosensitivity to cisplatin in human lung adenocarcinoma
Chun Li et al.
PATHOLOGY RESEARCH AND PRACTICE (2017)
Delayed and short course of rapamycin prevents organ rejection after allogeneic liver transplantation in rats
Salim Hamdani et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Blockage of FOXP3 transcription factor dimerization and FOXP3/AML1 interaction inhibits T regulatory cell activity: sequence optimization of a peptide inhibitor
Teresa Lozano et al.
ONCOTARGET (2017)
Therapeutic blockade of Foxp3 in experimental breast cancer models
Mariela A. Moreno Ayala et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
RUNX1 and FOXP3 interplay regulates expression of breast cancer related genes
Maria Sol Recouvreux et al.
ONCOTARGET (2016)
The COX- inhibitor indomethacin reduces Th1 effector and T regulatory cells in vitro in Mycobacterium tuberculosis infection
Kristian Tonby et al.
BMC INFECTIOUS DISEASES (2016)
Downregulation of FOXP3 inhibits invasion and immune escape in cholangiocarcinoma
Chao Ma et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
FOXP3+ regulatory T cells and their functional regulation
Zhiyuan Li et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2015)
TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer
Neil E. Bhola et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Searching for the Achilles heel of FOXP3
Teresa Lozano et al.
FRONTIERS IN ONCOLOGY (2013)
FOXP3 expression in tumor cells and tumor-infiltrating lymphocytes is associated with breast cancer prognosis
Miki Takenaka et al.
MOLECULAR AND CLINICAL ONCOLOGY (2013)
Denileukin diftitox in combination with rituximab for previously untreated follicular B-cell non-Hodgkin's lymphoma
S. M. Ansell et al.
LEUKEMIA (2012)
Transcription factor Foxp3 and its protein partners form a complex regulatory network
Dipayan Rudra et al.
NATURE IMMUNOLOGY (2012)
Tumor suppressor and T-regulatory functions of Foxp3 are mediated through separate signaling pathways
Emil Heinze et al.
ONCOLOGY LETTERS (2011)
B Cells Are Critical to T-cell-Mediated Antitumor Immunity Induced by a Combined Immune-Stimulatory/Conditionally Cytotoxic Therapy for Glioblastoma
Marianela Candolfi et al.
NEOPLASIA (2011)
Effects of cisplatin on matrix metalloproteinase-2 in transformed thyroid cells
L. Urso et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Dendritic Cell Vaccination in Combination with Anti-CD25 Monoclonal Antibody Treatment: A Phase I/II Study in Metastatic Melanoma Patients
Joannes F. M. Jacobs et al.
CLINICAL CANCER RESEARCH (2010)
Study of the Efficacy, Biodistribution, and Safety Profile of Therapeutic Gutless Adenovirus Vectors as a Prelude to a Phase I Clinical Trial for Glioblastoma
A. K. M. G. Muhammad et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
A Peptide Inhibitor of FOXP3 Impairs Regulatory T Cell Activity and Improves Vaccine Efficacy in Mice
Noelia Casares et al.
JOURNAL OF IMMUNOLOGY (2010)
A Novel Bicistronic High-Capacity Gutless Adenovirus Vector That Drives Constitutive Expression of Herpes Simplex Virus Type 1 Thymidine Kinase and Tet-Inducible Expression of Flt3L for Glioma Therapeutics
Mariana Puntel et al.
JOURNAL OF VIROLOGY (2010)
Possible involvement of regulatory T cells in tumor onset and progression in primary breast cancer
Masahiro Ohara et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Transcriptional Regulation of Foxp3 Gene: Multiple Signal Pathways on the Road
Zhu Shen et al.
MEDICINAL RESEARCH REVIEWS (2009)
Th2 lymphoproliferative disorder of LatY136F mutant mice unfolds independently of TCR-MHC engagement and is insensitive to the action of Foxp3+ regulatory T cells
Ying Wang et al.
JOURNAL OF IMMUNOLOGY (2008)
Cutting edge:: Broad expression of the FoxP3 locus in epithelial cells:: A caution against early interpretation of fatal inflammatory diseases following in vivo depletion of FoxP3-expressing cells
Guo-Yun Chen et al.
JOURNAL OF IMMUNOLOGY (2008)
Foxp3 expression in human cancer cells
Vaios Karanikas et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2008)
Regulatory T-cell inhibition versus depletion: the right choice in cancer immunotherapy
Mario P. Colombo et al.
NATURE REVIEWS CANCER (2007)
Foxp3 expression in pancreatic carcinoma cells as a novel mechanism of immune evasion in cancer
Sebastian Hinz et al.
CANCER RESEARCH (2007)
FOXP3 is an X-linked breast cancer suppressor gene and an important repressor of the HER-2/ErbB2 oncogene
Tao Zuo et al.
CELL (2007)
Intratumoral FOXP3 expression in infiltrating breast carcinoma: Its association with clinicopathologic parameters and angiogenesis.
Sachin Gupta et al.
ACTA ONCOLOGICA (2007)
Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients
Manuela Battaglia et al.
JOURNAL OF IMMUNOLOGY (2006)
FOXP3+CD4+CD25+ adaptive regulatory T cells express cyclooxygenase-2 and suppress effector T cells by a prostaglandin E2-dependent mechanism
Milada Mahic et al.
JOURNAL OF IMMUNOLOGY (2006)
Tumor-induced expansion of regulatory T cells by conversion of CD4+CD25- lymphocytes is thymus and proliferation independent
B Valzasina et al.
CANCER RESEARCH (2006)
TGF-β1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells
JC Marie et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
TGF-β induces Foxp3+T-regulatory cells from CD4+CD25-precursors
S Fu et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2004)
Adenoviral vector expressing murine angiostatin inhibits a model of breast cancer metastatic growth in the lungs of mice
S Gyorffy et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
IRES-dependent second gene expression is significantly lower than cap-dependent first gene expression in a bicistronic vector
H Mizuguchi et al.
MOLECULAR THERAPY (2000)
分享论文
